| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | nuclear speck | 3.94e-05 | 431 | 80 | 9 | GO:0016607 | |
| GeneOntologyCellularComponent | exon-exon junction complex | 6.83e-05 | 21 | 80 | 3 | GO:0035145 | |
| GeneOntologyCellularComponent | ASAP complex | 8.64e-05 | 4 | 80 | 2 | GO:0061574 | |
| GeneOntologyCellularComponent | nuclear body | NOLC1 SETD1A EAF1 SETD1B PNN RNPS1 NUFIP2 CHEK2 ACIN1 ZC3H18 SRRM2 PNISR | 1.58e-04 | 903 | 80 | 12 | GO:0016604 |
| GeneOntologyCellularComponent | microtubule end | 4.13e-04 | 38 | 80 | 3 | GO:1990752 | |
| GeneOntologyCellularComponent | intercellular bridge | 4.67e-04 | 94 | 80 | 4 | GO:0045171 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NOLC1 SETD1A NCOR1 EAF1 SETD1B PNN TENT4A RNPS1 FOSL2 ACIN1 MED1 SRRM2 TRIM37 SLX4 | 6.77e-04 | 1377 | 80 | 14 | GO:0140513 |
| GeneOntologyCellularComponent | Set1C/COMPASS complex | 1.68e-03 | 16 | 80 | 2 | GO:0048188 | |
| Domain | N-SET | 1.77e-05 | 2 | 79 | 2 | PF11764 | |
| Domain | COMPASS_Set1_N-SET | 1.77e-05 | 2 | 79 | 2 | IPR024657 | |
| Domain | Cell_morpho_N | 1.77e-05 | 2 | 79 | 2 | IPR025614 | |
| Domain | MOR2-PAG1_mid | 1.77e-05 | 2 | 79 | 2 | IPR029473 | |
| Domain | MOR2-PAG1_mid | 1.77e-05 | 2 | 79 | 2 | PF14228 | |
| Domain | MOR2-PAG1_C | 1.77e-05 | 2 | 79 | 2 | PF14225 | |
| Domain | MOR2-PAG1_N | 1.77e-05 | 2 | 79 | 2 | PF14222 | |
| Domain | N-SET | 1.77e-05 | 2 | 79 | 2 | SM01291 | |
| Domain | Cell_Morphogen_C | 1.77e-05 | 2 | 79 | 2 | IPR025481 | |
| Domain | DMAP_binding | 1.75e-04 | 5 | 79 | 2 | PF06464 | |
| Domain | DMAP1-bd | 2.62e-04 | 6 | 79 | 2 | IPR010506 | |
| Domain | DMAP_binding | 2.62e-04 | 6 | 79 | 2 | SM01137 | |
| Domain | Spectrin_alpha_SH3 | 1.79e-03 | 15 | 79 | 2 | IPR013315 | |
| Domain | Post-SET_dom | 2.04e-03 | 16 | 79 | 2 | IPR003616 | |
| Domain | PostSET | 2.04e-03 | 16 | 79 | 2 | SM00508 | |
| Domain | POST_SET | 2.04e-03 | 16 | 79 | 2 | PS50868 | |
| Domain | RRM | 2.27e-03 | 217 | 79 | 5 | SM00360 | |
| Domain | RRM_dom | 2.76e-03 | 227 | 79 | 5 | IPR000504 | |
| Domain | - | 3.75e-03 | 244 | 79 | 5 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 4.75e-03 | 258 | 79 | 5 | IPR012677 | |
| Domain | SH3_1 | 5.17e-03 | 164 | 79 | 4 | PF00018 | |
| Domain | AMP-binding | 7.12e-03 | 30 | 79 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 7.12e-03 | 30 | 79 | 2 | IPR000873 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 DIP2B PACS1 NCOR1 PNN RNPS1 FOSL2 USP24 FNBP4 ACIN1 BRD3 ZC3H18 MED1 GTF2IRD1 SRRM2 PNISR EMSY | 1.86e-12 | 774 | 80 | 17 | 15302935 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NOLC1 LENG8 SETD1A NCOR1 NUFIP2 ACIN1 ZC3H18 GREB1 MED1 SRRM2 EMSY | 3.93e-10 | 341 | 80 | 11 | 32971831 |
| Pubmed | 1.31e-09 | 87 | 80 | 7 | 12465718 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 LENG8 NCOR1 UBAP2 PNN CDKN2AIP NUFIP2 FNBP4 ACIN1 ZC3H18 MED1 SRRM2 SLX4 EMSY DDX3X | 4.23e-09 | 954 | 80 | 15 | 36373674 |
| Pubmed | 6.83e-09 | 251 | 80 | 9 | 31076518 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | DIP2B NCOR1 ZSWIM8 FRY SETD1B RNPS1 BTBD10 NUFIP2 USP24 NAV3 MTUS2 | 1.23e-08 | 475 | 80 | 11 | 31040226 |
| Pubmed | Pinin/DRS/memA interacts with SRp75, SRm300 and SRrp130 in corneal epithelial cells. | 4.68e-08 | 4 | 80 | 3 | 14578391 | |
| Pubmed | The structure of the ASAP core complex reveals the existence of a Pinin-containing PSAP complex. | 4.68e-08 | 4 | 80 | 3 | 22388736 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | LENG8 SETD1A UBAP2 SETD1B NUFIP2 FNBP4 MED1 ZBTB11 SLX4 DDX3X | 7.09e-08 | 440 | 80 | 10 | 34244565 |
| Pubmed | 1.38e-07 | 255 | 80 | 8 | 15324660 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 NCOR1 PNN RNPS1 FOSL2 FNBP4 ACIN1 BRD3 ZC3H18 MED1 GTF2IRD1 SRRM2 PNISR EMSY DDX3X | 2.29e-07 | 1294 | 80 | 15 | 30804502 |
| Pubmed | 2.44e-07 | 503 | 80 | 10 | 16964243 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | KRT13 KRT14 UBAP2 PNN RNPS1 JMJD6 ACIN1 BRD3 ZC3H18 SRRM2 DDX3X | 3.65e-07 | 665 | 80 | 11 | 30457570 |
| Pubmed | 4.20e-07 | 407 | 80 | 9 | 12693553 | ||
| Pubmed | 5.42e-07 | 549 | 80 | 10 | 38280479 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 6.50e-07 | 313 | 80 | 8 | 38270169 | |
| Pubmed | 6.65e-07 | 133 | 80 | 6 | 15144186 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 DIP2B KRT14 PNN FNBP4 ACIN1 BRD3 ZC3H18 MED1 GTF2IRD1 SRRM2 PNISR DDX3X | 1.09e-06 | 1082 | 80 | 13 | 38697112 |
| Pubmed | CLIP4 SPRY2 ZSWIM8 DIP2A FRY PPRC1 NAV3 RAP1GAP2 ZBTB11 PNISR TRIM37 MTUS2 SLX4 DDX3X | 1.27e-06 | 1285 | 80 | 14 | 35914814 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.30e-06 | 605 | 80 | 10 | 28977666 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A NCOR1 SPRY2 DIP2A HEG1 SETD1B PPRC1 FOSL2 RAP1GAP2 FRYL GTF2IRD1 SH2B2 SH3BP4 | 1.37e-06 | 1105 | 80 | 13 | 35748872 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FAM133B NOLC1 SETD1A NCOR1 UBE2E1 PNN RNPS1 JMJD6 CDKN2AIP USP24 ACIN1 SRRM2 EMSY DDX3X | 1.71e-06 | 1318 | 80 | 14 | 30463901 |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 2.18e-06 | 163 | 80 | 6 | 22113938 | |
| Pubmed | 2.40e-06 | 260 | 80 | 7 | 36199071 | ||
| Pubmed | NOLC1 ZSWIM8 PNN NUFIP2 USP24 ACIN1 FRYL ZC3H18 ZBTB11 SRRM2 | 2.57e-06 | 653 | 80 | 10 | 22586326 | |
| Pubmed | NOLC1 PNN RNPS1 CDKN2AIP NUFIP2 ACIN1 ZC3H18 ZBTB11 SRRM2 DDX3X | 2.64e-06 | 655 | 80 | 10 | 35819319 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 2.69e-06 | 169 | 80 | 6 | 23084401 | |
| Pubmed | 2.72e-06 | 42 | 80 | 4 | 35705031 | ||
| Pubmed | 2.93e-06 | 268 | 80 | 7 | 33640491 | ||
| Pubmed | LENG8 ROBO4 NCOR1 ZSWIM8 CD24 NAV3 ACIN1 FRYL GREB1 BCAR1 PNISR MTUS2 | 3.17e-06 | 1006 | 80 | 12 | 15226823 | |
| Pubmed | NCOR1 UBAP2 PNN RNPS1 NUFIP2 FNBP4 ACIN1 BRD3 ZC3H18 SRRM2 DDX3X | 3.80e-06 | 847 | 80 | 11 | 35850772 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 3.85e-06 | 533 | 80 | 9 | 30554943 | |
| Pubmed | 4.16e-06 | 103 | 80 | 5 | 32744500 | ||
| Pubmed | FAM133B NOLC1 NCOR1 KRT13 KRT14 PNN RNPS1 PPRC1 ITSN2 SKIDA1 ACIN1 BRD3 ZBTB11 PNISR | 4.84e-06 | 1442 | 80 | 14 | 35575683 | |
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 5.02e-06 | 107 | 80 | 5 | 20508642 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 24550110 | ||
| Pubmed | In Vivo and In Vitro Characterization of the RNA Binding Capacity of SETD1A (KMT2F). | 5.23e-06 | 2 | 80 | 2 | 38003223 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 14517304 | ||
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 6.01e-06 | 111 | 80 | 5 | 22558309 | |
| Pubmed | 7.14e-06 | 115 | 80 | 5 | 17332742 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 8.48e-06 | 588 | 80 | 9 | 38580884 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 LENG8 UBAP2 PNN RNPS1 CDKN2AIP NUFIP2 ACIN1 MED1 EMSY DDX3X | 9.56e-06 | 934 | 80 | 11 | 33916271 |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 21123813 | ||
| Pubmed | Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ. | 1.57e-05 | 3 | 80 | 2 | 30575522 | |
| Pubmed | ASAP, a novel protein complex involved in RNA processing and apoptosis. | 1.57e-05 | 3 | 80 | 2 | 12665594 | |
| Pubmed | Molecular insight into the SETD1A/B N-terminal region and its interaction with WDR82. | 1.57e-05 | 3 | 80 | 2 | 37030068 | |
| Pubmed | Exon Junction Complex Shapes the Transcriptome by Repressing Recursive Splicing. | 1.57e-05 | 3 | 80 | 2 | 30388411 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 17236128 | ||
| Pubmed | IQCJ-SCHIP1, a novel fusion transcript encoding a calmodulin-binding IQ motif protein. | 1.57e-05 | 3 | 80 | 2 | 17045569 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 1380418 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 16537548 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 24471966 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 33567280 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 12077342 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 24825908 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | FAM133B NOLC1 PNN RNPS1 NUFIP2 ACIN1 ZC3H18 SRRM2 PNISR DDX3X | 1.63e-05 | 807 | 80 | 10 | 22681889 |
| Pubmed | 1.65e-05 | 486 | 80 | 8 | 20936779 | ||
| Pubmed | 1.78e-05 | 491 | 80 | 8 | 36273042 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.03e-05 | 361 | 80 | 7 | 26167880 | |
| Pubmed | 2.18e-05 | 244 | 80 | 6 | 29884807 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 2.42e-05 | 148 | 80 | 5 | 32538781 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | NOLC1 ZSWIM8 SCHIP1 EAF1 RNPS1 CDKN2AIP RAP1GAP2 SNX16 PNISR TRIM37 DDX3X | 2.54e-05 | 1038 | 80 | 11 | 26673895 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 DIP2B UBAP2 PLEKHG3 OSBPL10 FRYL BCAR1 SRRM2 DDX3X SH3BP4 | 2.83e-05 | 861 | 80 | 10 | 36931259 |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.93e-05 | 154 | 80 | 5 | 16055720 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 3.05e-05 | 259 | 80 | 6 | 30404004 | |
| Pubmed | 3.12e-05 | 156 | 80 | 5 | 22952844 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 7518402 | ||
| Pubmed | Expression of cytokeratins 10, 13, 14 and 19 in oral lichen planus. | 3.13e-05 | 4 | 80 | 2 | 19776502 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 27979964 | ||
| Pubmed | Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. | 3.13e-05 | 4 | 80 | 2 | 24880342 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 3.16e-05 | 695 | 80 | 9 | 23602568 | |
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | 3.85e-05 | 270 | 80 | 6 | 24366813 | |
| Pubmed | 4.67e-05 | 731 | 80 | 9 | 29298432 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.99e-05 | 283 | 80 | 6 | 30585729 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 5.03e-05 | 922 | 80 | 10 | 27609421 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 25950943 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 25561738 | ||
| Pubmed | Checkpoint-dependent phosphorylation of Med1/TRAP220 in response to DNA damage. | 5.20e-05 | 5 | 80 | 2 | 28430840 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 18550753 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 9665399 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 6.24e-05 | 759 | 80 | 9 | 35915203 | |
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 7.34e-05 | 96 | 80 | 4 | 25948554 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 7.51e-05 | 444 | 80 | 7 | 34795231 | |
| Pubmed | 7.57e-05 | 188 | 80 | 5 | 29721183 | ||
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 17468099 | ||
| Pubmed | Amino acids important for ligand specificity of the human constitutive androstane receptor. | 7.79e-05 | 6 | 80 | 2 | 15572376 | |
| Pubmed | Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core. | 7.79e-05 | 6 | 80 | 2 | 16314458 | |
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 27506116 | ||
| Pubmed | 9.00e-05 | 195 | 80 | 5 | 19454010 | ||
| Pubmed | 1.00e-04 | 104 | 80 | 4 | 10470851 | ||
| Pubmed | Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. | 1.00e-04 | 104 | 80 | 4 | 26167872 | |
| Pubmed | 1.04e-04 | 105 | 80 | 4 | 9628581 | ||
| Pubmed | NOLC1 EVI5 LENG8 PLEKHG3 CDKN2AIP DBNDD2 USP24 FNBP4 ZC3H18 BCAR1 TRIM37 | 1.04e-04 | 1215 | 80 | 11 | 15146197 | |
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 19433449 | ||
| Pubmed | Importin-11, a nuclear import receptor for the ubiquitin-conjugating enzyme, UbcM2. | 1.09e-04 | 7 | 80 | 2 | 11032817 | |
| Pubmed | NOLC1 NCOR1 UBE2E1 PNN JMJD6 CDKN2AIP ACIN1 BRD3 ZC3H18 MED1 | 1.10e-04 | 1014 | 80 | 10 | 32416067 | |
| Pubmed | NOLC1 NCOR1 EAF1 PNN RNPS1 NUFIP2 ACIN1 MED1 SRRM2 DDX3X SH3BP4 | 1.31e-04 | 1247 | 80 | 11 | 27684187 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 KRT13 KRT14 PNN RNPS1 PLEKHG3 BTBD10 NUFIP2 ACIN1 ZC3H18 DDX3X | 1.40e-04 | 1257 | 80 | 11 | 36526897 |
| Pubmed | 1.41e-04 | 660 | 80 | 8 | 32780723 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 18680430 | ||
| Interaction | PIP4K2A interactions | NOLC1 LENG8 EAF1 SETD1B PNN RNPS1 PPRC1 JMJD6 NUFIP2 ACIN1 BRD3 SRRM2 PNISR | 2.43e-12 | 216 | 79 | 13 | int:PIP4K2A |
| Interaction | NFKBIL1 interactions | 2.96e-12 | 93 | 79 | 10 | int:NFKBIL1 | |
| Interaction | CAMKV interactions | 8.67e-10 | 118 | 79 | 9 | int:CAMKV | |
| Interaction | C1orf35 interactions | EAF1 PNN RNPS1 JMJD6 NUFIP2 ACIN1 BRD3 ZC3H18 SRRM2 MTUS2 SLX4 | 2.79e-08 | 304 | 79 | 11 | int:C1orf35 |
| Interaction | SON interactions | 1.23e-07 | 208 | 79 | 9 | int:SON | |
| Interaction | DENND2D interactions | 2.79e-07 | 36 | 79 | 5 | int:DENND2D | |
| Interaction | MEN1 interactions | NOLC1 LENG8 SETD1A NCOR1 UBAP2 SETD1B PNN RNPS1 FOSL2 NUFIP2 FNBP4 ACIN1 ZC3H18 GREB1 MED1 SRRM2 EMSY | 3.81e-07 | 1029 | 79 | 17 | int:MEN1 |
| Interaction | CSNK2A1 interactions | NOLC1 PACS1 SETD1A NCOR1 PNN RNPS1 JMJD6 USP24 FNBP4 CHEK2 HLX ACIN1 BRD3 ZC3H18 SRRM2 DDX3X | 7.50e-07 | 956 | 79 | 16 | int:CSNK2A1 |
| Interaction | NKAP interactions | 8.63e-07 | 132 | 79 | 7 | int:NKAP | |
| Interaction | PPP1CC interactions | LENG8 CSRNP1 NCOR1 PNN RNPS1 BTBD10 ITSN2 ACIN1 ZC3H18 SRRM2 TRIM37 SLX4 EMSY DDX3X | 9.45e-07 | 738 | 79 | 14 | int:PPP1CC |
| Interaction | DAXX interactions | 1.18e-06 | 353 | 79 | 10 | int:DAXX | |
| Interaction | SMC5 interactions | NOLC1 LENG8 NCOR1 UBAP2 PNN CDKN2AIP NUFIP2 FNBP4 ACIN1 ZC3H18 BCAR1 MED1 SRRM2 SLX4 EMSY DDX3X | 1.36e-06 | 1000 | 79 | 16 | int:SMC5 |
| Interaction | CFAP20 interactions | 1.53e-06 | 91 | 79 | 6 | int:CFAP20 | |
| Interaction | ZMYND11 interactions | 1.85e-06 | 94 | 79 | 6 | int:ZMYND11 | |
| Interaction | RBBP6 interactions | 2.08e-06 | 216 | 79 | 8 | int:RBBP6 | |
| Interaction | SFSWAP interactions | 2.10e-06 | 96 | 79 | 6 | int:SFSWAP | |
| Interaction | AKAP17A interactions | 2.51e-06 | 99 | 79 | 6 | int:AKAP17A | |
| Interaction | EPB41L2 interactions | 2.56e-06 | 299 | 79 | 9 | int:EPB41L2 | |
| Interaction | SAP18 interactions | 3.01e-06 | 305 | 79 | 9 | int:SAP18 | |
| Interaction | RSBN1 interactions | 3.26e-06 | 161 | 79 | 7 | int:RSBN1 | |
| Interaction | FAM9A interactions | 3.45e-06 | 59 | 79 | 5 | int:FAM9A | |
| Interaction | MCRS1 interactions | 3.88e-06 | 235 | 79 | 8 | int:MCRS1 | |
| Interaction | DDX41 interactions | 3.99e-06 | 166 | 79 | 7 | int:DDX41 | |
| Interaction | NUP43 interactions | SETD1A NCOR1 SETD1B PNN RNPS1 CDKN2AIP ACIN1 ZC3H18 ZBTB11 SRRM2 SLX4 EMSY | 5.47e-06 | 625 | 79 | 12 | int:NUP43 |
| Interaction | CPSF6 interactions | LENG8 PNN RNPS1 JMJD6 ITSN2 NUFIP2 ACIN1 ZC3H18 SRRM2 TRIM37 DDX3X | 6.27e-06 | 526 | 79 | 11 | int:CPSF6 |
| Interaction | BRD9 interactions | 6.62e-06 | 117 | 79 | 6 | int:BRD9 | |
| Interaction | PES1 interactions | 7.71e-06 | 258 | 79 | 8 | int:PES1 | |
| Interaction | PRPF40A interactions | 9.39e-06 | 446 | 79 | 10 | int:PRPF40A | |
| Interaction | LUC7L2 interactions | 9.81e-06 | 353 | 79 | 9 | int:LUC7L2 | |
| Interaction | ATXN1 interactions | NCOR1 ZSWIM8 DIP2A KRT13 KRT14 UBAP2 UBE2E1 PNN RNPS1 JMJD6 ACIN1 BRD3 ZC3H18 SRRM2 TRIM37 | 1.06e-05 | 1039 | 79 | 15 | int:ATXN1 |
| Interaction | ZNF281 interactions | 1.23e-05 | 197 | 79 | 7 | int:ZNF281 | |
| Interaction | SRSF11 interactions | 1.49e-05 | 203 | 79 | 7 | int:SRSF11 | |
| Interaction | DHX8 interactions | 1.89e-05 | 292 | 79 | 8 | int:DHX8 | |
| Interaction | MFAP1 interactions | 2.03e-05 | 295 | 79 | 8 | int:MFAP1 | |
| Interaction | CLK3 interactions | 2.50e-05 | 220 | 79 | 7 | int:CLK3 | |
| Interaction | MECP2 interactions | NOLC1 LENG8 DIP2B NCOR1 KRT14 PNN NUFIP2 FNBP4 ACIN1 BRD3 ZC3H18 MED1 GTF2IRD1 SRRM2 PNISR DDX3X | 3.27e-05 | 1287 | 79 | 16 | int:MECP2 |
| Interaction | BUB3 interactions | 3.51e-05 | 232 | 79 | 7 | int:BUB3 | |
| Interaction | SNRNP40 interactions | LENG8 NCOR1 PNN CDKN2AIP ITSN2 ACIN1 ZC3H18 ZBTB11 SRRM2 PNISR EMSY | 3.71e-05 | 637 | 79 | 11 | int:SNRNP40 |
| Interaction | TOPORS interactions | 3.77e-05 | 96 | 79 | 5 | int:TOPORS | |
| Interaction | RBM25 interactions | 3.88e-05 | 323 | 79 | 8 | int:RBM25 | |
| Interaction | TOP3B interactions | SETD1A NCOR1 SPRY2 DIP2A HEG1 UBAP2 SETD1B PPRC1 FOSL2 NUFIP2 RAP1GAP2 ACIN1 FRYL GTF2IRD1 SH2B2 DDX3X SH3BP4 | 4.45e-05 | 1470 | 79 | 17 | int:TOP3B |
| Interaction | LUC7L interactions | 4.59e-05 | 242 | 79 | 7 | int:LUC7L | |
| Interaction | PNISR interactions | 4.75e-05 | 51 | 79 | 4 | int:PNISR | |
| Interaction | NUP50 interactions | 5.68e-05 | 341 | 79 | 8 | int:NUP50 | |
| Interaction | ARGLU1 interactions | 6.68e-05 | 176 | 79 | 6 | int:ARGLU1 | |
| Interaction | CHD4 interactions | NOLC1 SETD1A KRT13 KRT14 PNN NUFIP2 FNBP4 ACIN1 BRD3 ZC3H18 SRRM2 SLX4 DDX3X | 6.74e-05 | 938 | 79 | 13 | int:CHD4 |
| Interaction | RAD18 interactions | 7.40e-05 | 457 | 79 | 9 | int:RAD18 | |
| Interaction | MAGOH interactions | 7.93e-05 | 264 | 79 | 7 | int:MAGOH | |
| Interaction | EDA interactions | 8.21e-05 | 113 | 79 | 5 | int:EDA | |
| Interaction | RSBN1L interactions | 8.56e-05 | 114 | 79 | 5 | int:RSBN1L | |
| Interaction | YWHAG interactions | NOLC1 PACS1 UBAP2 PNN RNPS1 PLEKHG3 NUFIP2 USP24 OSBPL10 ACIN1 FRYL BCAR1 SRRM2 DDX3X SH3BP4 | 8.80e-05 | 1248 | 79 | 15 | int:YWHAG |
| Interaction | EPB41L1 interactions | 9.34e-05 | 187 | 79 | 6 | int:EPB41L1 | |
| Interaction | EPB41L3 interactions | 9.56e-05 | 272 | 79 | 7 | int:EPB41L3 | |
| Interaction | ELAVL2 interactions | 9.61e-05 | 188 | 79 | 6 | int:ELAVL2 | |
| Interaction | RBM33 interactions | 9.68e-05 | 117 | 79 | 5 | int:RBM33 | |
| Interaction | PTGER3 interactions | 1.01e-04 | 118 | 79 | 5 | int:PTGER3 | |
| Interaction | PLCD3 interactions | 1.14e-04 | 121 | 79 | 5 | int:PLCD3 | |
| Interaction | PPIE interactions | 1.20e-04 | 282 | 79 | 7 | int:PPIE | |
| Interaction | RNF151 interactions | 1.23e-04 | 123 | 79 | 5 | int:RNF151 | |
| Interaction | HDAC4 interactions | DIP2B NCOR1 ZSWIM8 FRY SETD1B RNPS1 BTBD10 NUFIP2 USP24 NAV3 MTUS2 | 1.48e-04 | 744 | 79 | 11 | int:HDAC4 |
| Interaction | SIRT6 interactions | LENG8 SETD1A UBAP2 SETD1B NUFIP2 FNBP4 MED1 ZBTB11 SLX4 DDX3X | 1.67e-04 | 628 | 79 | 10 | int:SIRT6 |
| Interaction | ACIN1 interactions | 1.79e-04 | 301 | 79 | 7 | int:ACIN1 | |
| Interaction | PNN interactions | 1.82e-04 | 302 | 79 | 7 | int:PNN | |
| Interaction | SUPT5H interactions | 1.96e-04 | 408 | 79 | 8 | int:SUPT5H | |
| Interaction | CLK1 interactions | 2.21e-04 | 219 | 79 | 6 | int:CLK1 | |
| Interaction | CCDC154 interactions | 2.25e-04 | 6 | 79 | 2 | int:CCDC154 | |
| Interaction | SNIP1 interactions | 2.27e-04 | 417 | 79 | 8 | int:SNIP1 | |
| Interaction | SCAF4 interactions | 2.32e-04 | 141 | 79 | 5 | int:SCAF4 | |
| Interaction | PABPC5 interactions | 2.40e-04 | 142 | 79 | 5 | int:PABPC5 | |
| Interaction | ERG interactions | 2.43e-04 | 223 | 79 | 6 | int:ERG | |
| Interaction | UBE2O interactions | CLIP4 NOLC1 KRT14 UBAP2 EAF1 PNN RNPS1 CHEK2 ACIN1 SRRM2 EMSY | 2.49e-04 | 790 | 79 | 11 | int:UBE2O |
| Interaction | FOXK2 interactions | 2.55e-04 | 225 | 79 | 6 | int:FOXK2 | |
| Interaction | FIP1L1 interactions | 2.55e-04 | 225 | 79 | 6 | int:FIP1L1 | |
| Interaction | RNPS1 interactions | 2.58e-04 | 425 | 79 | 8 | int:RNPS1 | |
| Interaction | PAIP1 interactions | 2.73e-04 | 146 | 79 | 5 | int:PAIP1 | |
| Interaction | BRD2 interactions | 2.75e-04 | 429 | 79 | 8 | int:BRD2 | |
| Interaction | PRP4K interactions | 3.07e-04 | 329 | 79 | 7 | int:PRP4K | |
| Interaction | SYT2 interactions | 3.09e-04 | 150 | 79 | 5 | int:SYT2 | |
| Interaction | YAP1 interactions | FAM133B SETD1A NCOR1 KRT14 UBAP2 PNN NUFIP2 FNBP4 ACIN1 MED1 SRRM2 TRIM37 DDX3X | 3.12e-04 | 1095 | 79 | 13 | int:YAP1 |
| Interaction | NR2C2 interactions | FAM133B NOLC1 SETD1A NCOR1 UBE2E1 PNN RNPS1 JMJD6 CDKN2AIP ITSN2 USP24 ACIN1 SRRM2 EMSY DDX3X | 3.18e-04 | 1403 | 79 | 15 | int:NR2C2 |
| Interaction | BRCA1 interactions | NOLC1 GPR161 SETD1A UBAP2 UBE2E1 RNPS1 CDKN2AIP FOSL2 NUFIP2 FNBP4 CHEK2 GTF2IRD1 SLX4 EMSY | 3.22e-04 | 1249 | 79 | 14 | int:BRCA1 |
| Interaction | SNRPC interactions | 3.26e-04 | 440 | 79 | 8 | int:SNRPC | |
| Interaction | YWHAH interactions | NOLC1 DIP2B PACS1 UBAP2 PNN PLEKHG3 OSBPL10 FRYL BCAR1 MED1 SRRM2 DDX3X SH3BP4 | 3.32e-04 | 1102 | 79 | 13 | int:YWHAH |
| Interaction | TLE5 interactions | 3.41e-04 | 443 | 79 | 8 | int:TLE5 | |
| Interaction | DET1 interactions | 3.60e-04 | 155 | 79 | 5 | int:DET1 | |
| Interaction | LARP4B interactions | 3.61e-04 | 240 | 79 | 6 | int:LARP4B | |
| Interaction | RNF113A interactions | NOLC1 PNN RNPS1 CDKN2AIP NUFIP2 ACIN1 ZC3H18 ZBTB11 SRRM2 DDX3X | 3.63e-04 | 692 | 79 | 10 | int:RNF113A |
| Interaction | KRT6A interactions | 4.16e-04 | 160 | 79 | 5 | int:KRT6A | |
| Interaction | NKAPD1 interactions | 4.28e-04 | 161 | 79 | 5 | int:NKAPD1 | |
| Interaction | KPNA3 interactions | 4.29e-04 | 248 | 79 | 6 | int:KPNA3 | |
| Interaction | SRRM1 interactions | 4.30e-04 | 348 | 79 | 7 | int:SRRM1 | |
| Interaction | SRRM2 interactions | 4.51e-04 | 462 | 79 | 8 | int:SRRM2 | |
| Interaction | PRMT2 interactions | 4.51e-04 | 91 | 79 | 4 | int:PRMT2 | |
| Interaction | PIAS1 interactions | 4.69e-04 | 353 | 79 | 7 | int:PIAS1 | |
| Interaction | PCID2 interactions | 4.70e-04 | 92 | 79 | 4 | int:PCID2 | |
| Interaction | PRPS2 interactions | 4.77e-04 | 253 | 79 | 6 | int:PRPS2 | |
| Interaction | SRPK2 interactions | 4.80e-04 | 717 | 79 | 10 | int:SRPK2 | |
| Interaction | SNRPB2 interactions | 4.97e-04 | 255 | 79 | 6 | int:SNRPB2 | |
| Interaction | CPSF4 interactions | 5.10e-04 | 94 | 79 | 4 | int:CPSF4 | |
| Interaction | SARNP interactions | 5.20e-04 | 168 | 79 | 5 | int:SARNP | |
| GeneFamily | ASAP complex|SIN3 histone deacetylase complex | 1.66e-05 | 3 | 43 | 2 | 1236 | |
| GeneFamily | CD molecules|Mucins | 1.13e-03 | 21 | 43 | 2 | 648 | |
| GeneFamily | RNA binding motif containing | 1.61e-03 | 213 | 43 | 4 | 725 | |
| GeneFamily | Keratins, type I | 2.01e-03 | 28 | 43 | 2 | 608 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.95e-03 | 34 | 43 | 2 | 487 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 3.96e-03 | 134 | 43 | 3 | 861 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.59e-03 | 161 | 43 | 3 | 593 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.08e-02 | 66 | 43 | 2 | 722 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 1.52e-06 | 265 | 80 | 8 | M1684 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 1.84e-06 | 272 | 80 | 8 | MM1027 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 2.69e-06 | 200 | 80 | 7 | M5282 | |
| Coexpression | CSR_EARLY_UP.V1_UP | 7.55e-06 | 153 | 80 | 6 | M2656 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 9.11e-06 | 338 | 80 | 8 | M17094 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EVI5 SCHIP1 HEG1 UBE2E1 ITSN2 USP24 NAV3 FRYL MED1 ZBTB11 PNISR TRIM37 | 1.07e-05 | 856 | 80 | 12 | M4500 |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP | 1.38e-05 | 170 | 80 | 6 | M6697 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 2.15e-05 | 184 | 80 | 6 | M19988 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP | 2.22e-05 | 185 | 80 | 6 | M8792 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | 2.31e-05 | 504 | 80 | 9 | M2157 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_SCC_DN | 2.75e-05 | 115 | 80 | 5 | M7484 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 3.35e-05 | 199 | 80 | 6 | M9443 | |
| Coexpression | GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP | 3.44e-05 | 200 | 80 | 6 | M3364 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.73e-05 | 300 | 80 | 7 | M8702 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | CLIP4 ANKRD13B CSRNP1 FRY HEG1 PLEKHG3 FOSL2 DBNDD2 PKHD1L1 SH3BP4 | 5.55e-05 | 704 | 80 | 10 | M45672 |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 6.82e-05 | 139 | 80 | 5 | M8948 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 8.89e-05 | 466 | 80 | 8 | M13522 | |
| Coexpression | GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP | 1.05e-04 | 30 | 80 | 3 | M19107 | |
| Coexpression | BROWNE_HCMV_INFECTION_14HR_UP | 1.18e-04 | 156 | 80 | 5 | M17225 | |
| Coexpression | ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_DN | 1.27e-04 | 32 | 80 | 3 | M40951 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D5 | 1.67e-04 | 35 | 80 | 3 | M13814 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN | 1.80e-04 | 171 | 80 | 5 | M8820 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | GPR161 SPRY2 JMJD6 CDKN2AIP FOSL2 ITSN2 FNBP4 SNX16 GTF2IRD1 PNISR | 1.97e-04 | 822 | 80 | 10 | M6782 |
| Coexpression | BHAT_ESR1_TARGETS_VIA_AKT1_UP | 2.23e-04 | 281 | 80 | 6 | M2234 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 2.25e-04 | 97 | 80 | 4 | M14698 | |
| Coexpression | WANG_CLIM2_TARGETS_DN | 2.41e-04 | 182 | 80 | 5 | M8577 | |
| Coexpression | GENTILE_UV_HIGH_DOSE_DN | 2.59e-04 | 289 | 80 | 6 | M13630 | |
| Coexpression | YAGI_AML_WITH_INV_16_TRANSLOCATION | 2.63e-04 | 411 | 80 | 7 | M1047 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 2.87e-04 | 417 | 80 | 7 | M39224 | |
| Coexpression | LASTOWSKA_COAMPLIFIED_WITH_MYCN | 3.09e-04 | 43 | 80 | 3 | M1375 | |
| Coexpression | SCHMAHL_PDGF_SIGNALING | 3.27e-04 | 9 | 80 | 2 | MM538 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 3.55e-04 | 432 | 80 | 7 | M41149 | |
| Coexpression | GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP | 3.72e-04 | 200 | 80 | 5 | M6473 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN | 3.72e-04 | 200 | 80 | 5 | M6240 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 3.72e-04 | 200 | 80 | 5 | M9313 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP | 3.72e-04 | 200 | 80 | 5 | M328 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP | 3.72e-04 | 200 | 80 | 5 | M4524 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | 3.72e-04 | 200 | 80 | 5 | M8306 | |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN | 3.72e-04 | 200 | 80 | 5 | M3575 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 3.72e-04 | 200 | 80 | 5 | M8497 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 3.72e-04 | 200 | 80 | 5 | M9258 | |
| Coexpression | SCHMAHL_PDGF_SIGNALING | 4.07e-04 | 10 | 80 | 2 | M1285 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.99e-11 | 200 | 80 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.84e-08 | 193 | 80 | 7 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 7.45e-08 | 200 | 80 | 7 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.50e-06 | 197 | 80 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.59e-06 | 199 | 80 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 180 | 80 | 5 | 3d95232b5785c705f41e01e3ffe0fa8dce1ff0a7 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 180 | 80 | 5 | 47e345359064dc8ceec982b062e47802e728b43f | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 180 | 80 | 5 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 180 | 80 | 5 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 181 | 80 | 5 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 181 | 80 | 5 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 182 | 80 | 5 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 182 | 80 | 5 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 188 | 80 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 188 | 80 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.31e-05 | 189 | 80 | 5 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-05 | 192 | 80 | 5 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.55e-05 | 193 | 80 | 5 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 194 | 80 | 5 | 0e9830ad070c47acaa952400bf2a3ddbff664a2f | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.62e-05 | 194 | 80 | 5 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.68e-05 | 195 | 80 | 5 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.68e-05 | 195 | 80 | 5 | 6da69e3eba036936f44bc052996ad12b6309055e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.75e-05 | 196 | 80 | 5 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | NS-control-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.82e-05 | 197 | 80 | 5 | ab965a0ba87efd3329d24a1ec123985f46fc17c0 | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 2.82e-05 | 197 | 80 | 5 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.82e-05 | 197 | 80 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | moderate-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.82e-05 | 197 | 80 | 5 | 2e13881f917d4f62a5b3e968e41c57e43300d988 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.89e-05 | 198 | 80 | 5 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.89e-05 | 198 | 80 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | control-Epithelial-Squamous|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.89e-05 | 198 | 80 | 5 | 6ba669ac1ed275ae309054941b1457e315766faa | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.89e-05 | 198 | 80 | 5 | 9895f1d65d18d939f3974a914ee41c6d5575e765 | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.89e-05 | 198 | 80 | 5 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.89e-05 | 198 | 80 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | control-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.96e-05 | 199 | 80 | 5 | e13dca7a055cdca53dd6c26c04b2a46d58b419b6 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-05 | 199 | 80 | 5 | 5a1557fe35aa48080d4967e8724bf27f9585a5fb | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-05 | 199 | 80 | 5 | 0a657475b92aa3a713da62da364525249fdc3886 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-05 | 199 | 80 | 5 | a8f4bd0e65f36b29535864fae4347369d5c864d2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-05 | 199 | 80 | 5 | 667e1a56c33a2681af8dc1b7dbc3a9858e2c3c05 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-05 | 199 | 80 | 5 | 245b37df56dfbbdbac88f0e2fc3dfa0ed1abd588 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.96e-05 | 199 | 80 | 5 | 0902b08e3386e64d7347c186d9ce5b67f2deaabb | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-05 | 199 | 80 | 5 | 2dae9db4d25f1a390134da2b6621564b274fe910 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-05 | 199 | 80 | 5 | eacea42e973f073b410f54c0a1b3a7f2dc2b5a29 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.96e-05 | 199 | 80 | 5 | 1aa963ed5205d6d52262b1597a5d08707a95c3ca | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-05 | 199 | 80 | 5 | dbb33f0e151b150ba9ca4612973f8034c62e762b | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 2.96e-05 | 199 | 80 | 5 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-05 | 200 | 80 | 5 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.43e-04 | 147 | 80 | 4 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.50e-04 | 149 | 80 | 4 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.54e-04 | 150 | 80 | 4 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | VE-CD8-memory_CD4|VE / Condition, Cell_class and T cell subcluster | 1.62e-04 | 152 | 80 | 4 | 9401b7770c1bdc87eba25e82922f5dd1c4fa37ee | |
| ToppCell | facs-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 156 | 80 | 4 | f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 156 | 80 | 4 | da4f35353a84d919e683554932f110e29568df33 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 156 | 80 | 4 | f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 157 | 80 | 4 | 9021900d9b1a71210c9c414a9d165eaf399eb607 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 157 | 80 | 4 | c8c627ca181856cd31dba4cf073c2be659a49dc1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 158 | 80 | 4 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | droplet-Heart-nan-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 161 | 80 | 4 | eb546d5065ac506405d240f9a1f55f2122d0c368 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.12e-04 | 163 | 80 | 4 | 6a12b802cb181f979ebc72674f3626fb855024e3 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue | 2.12e-04 | 163 | 80 | 4 | 30f5c93c4e170304d701b5231f0d545f404066f7 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 165 | 80 | 4 | 4fe7c3c9370a556cf4e308a2e723b4b907a6cc25 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.32e-04 | 167 | 80 | 4 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.32e-04 | 167 | 80 | 4 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | T_cells-GNLY+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.54e-04 | 171 | 80 | 4 | 04c811817cfec45af5f2891793106cc7ddb0300e | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 171 | 80 | 4 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | facs-Heart-RV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 172 | 80 | 4 | a26a73c41e5a05c9dd47a99f3320295f684c5e54 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 172 | 80 | 4 | 84d16cd7f618c94888920680bdc9e7130d73fd75 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-04 | 173 | 80 | 4 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Squamous|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.72e-04 | 174 | 80 | 4 | 0a4721248ec89bc98ebe119de6e19fbfca8b5098 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.72e-04 | 174 | 80 | 4 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | facs-Heart-RV-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 175 | 80 | 4 | bde002379088c0407afd0f3dae60b6a166683957 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.90e-04 | 177 | 80 | 4 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.96e-04 | 178 | 80 | 4 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 178 | 80 | 4 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 178 | 80 | 4 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | 3'_v3|World / Manually curated celltypes from each tissue | 2.96e-04 | 178 | 80 | 4 | 42502f14d9c756df8104900ac6484477b885d3d9 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.96e-04 | 178 | 80 | 4 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | C_00|World / shred on cell type and cluster | 3.03e-04 | 179 | 80 | 4 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-04 | 180 | 80 | 4 | c0c07937839652e01df10cc1e70aa005800ea6f6 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-04 | 180 | 80 | 4 | 079c199425dd3c220f03c6dca1823946f07580a1 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 3.09e-04 | 180 | 80 | 4 | 237a2130a3f48595dad2417539c21e44585962b8 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.09e-04 | 180 | 80 | 4 | 2ccc77d769d3ffd77ab3af45e4f192785b6db79c | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-04 | 180 | 80 | 4 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 181 | 80 | 4 | a5e770b5b5d57cbac18560828e89f7c96b687743 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 181 | 80 | 4 | 504b1af1951a7a20ef5db69d84c20630ec64095b | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 181 | 80 | 4 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 181 | 80 | 4 | a55ec36d2393f7a376feb42b22aee75dfdf4c383 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.16e-04 | 181 | 80 | 4 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-04 | 181 | 80 | 4 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | droplet-Heart-nan-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 181 | 80 | 4 | 859c40889ede2cbf374c4d2efbb72dc3bc6441f5 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-04 | 182 | 80 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 182 | 80 | 4 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.29e-04 | 183 | 80 | 4 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-04 | 183 | 80 | 4 | 29defb21458bc43d22ca5e4d08218db45aaa1add | |
| ToppCell | PSB-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.29e-04 | 183 | 80 | 4 | 2cf798a2371c61322484ea16fdfae0acfa94f102 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-04 | 184 | 80 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-04 | 184 | 80 | 4 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.36e-04 | 184 | 80 | 4 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.43e-04 | 185 | 80 | 4 | 05e6eb78ead81268c1656e7ffe34f9cb7329b908 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 185 | 80 | 4 | dec60254204014083ff3b4aec0cc75410950a486 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.43e-04 | 185 | 80 | 4 | f3fbc3096f85397a959cee17c3c4fcf2d511f3d5 | |
| Drug | Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; PC3; HG-U133A | 4.46e-07 | 196 | 80 | 8 | 1917_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.04e-06 | 167 | 80 | 7 | 5217_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.21e-06 | 169 | 80 | 7 | 5572_DN | |
| Drug | mosidal | 2.33e-06 | 27 | 80 | 4 | CID003032288 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.78e-06 | 175 | 80 | 7 | 1014_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.00e-06 | 177 | 80 | 7 | 873_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.12e-06 | 178 | 80 | 7 | 992_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.12e-06 | 178 | 80 | 7 | 6276_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.36e-06 | 180 | 80 | 7 | 6454_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.38e-05 | 163 | 80 | 6 | 7453_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.55e-05 | 165 | 80 | 6 | 5625_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.64e-05 | 166 | 80 | 6 | 7324_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.02e-05 | 170 | 80 | 6 | 1050_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.22e-05 | 172 | 80 | 6 | 3428_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.22e-05 | 172 | 80 | 6 | 2330_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.44e-05 | 174 | 80 | 6 | 5940_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.67e-05 | 176 | 80 | 6 | 981_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.67e-05 | 176 | 80 | 6 | 6932_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.67e-05 | 176 | 80 | 6 | 1535_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 3.78e-05 | 177 | 80 | 6 | 1645_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.78e-05 | 177 | 80 | 6 | 6551_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.78e-05 | 177 | 80 | 6 | 6434_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.91e-05 | 178 | 80 | 6 | 1672_DN | |
| Drug | deoxynivalenol | 4.78e-05 | 481 | 80 | 9 | ctd:C007262 | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 4.99e-05 | 186 | 80 | 6 | 6793_UP | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 5.46e-05 | 189 | 80 | 6 | 6997_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A | 5.46e-05 | 189 | 80 | 6 | 410_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 5.62e-05 | 190 | 80 | 6 | 1074_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 5.95e-05 | 192 | 80 | 6 | 5058_DN | |
| Drug | Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; HL60; HG-U133A | 6.31e-05 | 194 | 80 | 6 | 1741_DN | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 4556_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 6941_DN | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; HL60; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 2543_DN | |
| Drug | Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 7256_UP | |
| Drug | Thiorphan [76721-89-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 7.26e-05 | 199 | 80 | 6 | 6249_DN | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HG-U133A | 7.46e-05 | 200 | 80 | 6 | 1953_DN | |
| Drug | AC1NTGJT | 1.21e-04 | 5 | 80 | 2 | CID005380670 | |
| Drug | dihydrodigoxin | 1.21e-04 | 5 | 80 | 2 | CID000092217 | |
| Disease | neurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology) | 7.26e-06 | 2 | 80 | 2 | DOID:0070417 (implicated_via_orthology) | |
| Disease | brain-derived neurotrophic factor measurement | 3.93e-04 | 11 | 80 | 2 | EFO_0011018 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 9.61e-04 | 17 | 80 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Endometrioma | 9.78e-04 | 161 | 80 | 4 | C0269102 | |
| Disease | Endometriosis | 9.78e-04 | 161 | 80 | 4 | C0014175 | |
| Disease | asthma, allergic disease | 1.31e-03 | 79 | 80 | 3 | MONDO_0004979, MONDO_0005271 | |
| Disease | Intellectual Disability | 1.37e-03 | 447 | 80 | 6 | C3714756 | |
| Disease | migraine disorder, Headache | 1.67e-03 | 86 | 80 | 3 | HP_0002315, MONDO_0005277 | |
| Disease | corpus callosum volume measurement | 2.57e-03 | 100 | 80 | 3 | EFO_0010299 | |
| Disease | Breast Cancer, Familial | 3.01e-03 | 30 | 80 | 2 | C0346153 | |
| Disease | Mammary Carcinoma, Human | 3.05e-03 | 525 | 80 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.05e-03 | 525 | 80 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 3.11e-03 | 527 | 80 | 6 | C1458155 | |
| Disease | aspartate aminotransferase measurement | 3.12e-03 | 904 | 80 | 8 | EFO_0004736 | |
| Disease | obsolete_red blood cell distribution width | GPR161 DIP2B SETD1B TENT4A NUFIP2 PCIF1 CHEK2 CLMP BRD3 TMEM40 | 3.43e-03 | 1347 | 80 | 10 | EFO_0005192 |
| Disease | Breast Carcinoma | 3.44e-03 | 538 | 80 | 6 | C0678222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KQSADSSSSRSSSSS | 571 | Q9UKV3 | |
| SAGNSSRNSSQSSSD | 126 | Q9BSF8 | |
| RLSSSSSSESGSSSS | 701 | Q15059 | |
| SSETTTGTSSNSSQS | 26 | P25063 | |
| SDGSTSSDTTSNSFV | 41 | Q02641 | |
| STGSTRSSQSASSLE | 431 | P56945 | |
| SSSQSQGISSSSTST | 31 | O96017 | |
| SSRASAGLNSSATST | 461 | Q8N3C7 | |
| TDSTSSTASSTSNRS | 716 | Q6ZUJ8 | |
| QMSSSSGSSSSDSES | 186 | Q96JC9 | |
| RSSSVSSVSSTQSGD | 856 | Q5JR59 | |
| NGKAASSSSSSSSSS | 211 | Q14978 | |
| SSSSTSSTASLSGNS | 216 | Q9NZM3 | |
| SSSVSSSSSTTSCRG | 461 | Q86YJ7 | |
| SGASSSSFSSSRASS | 606 | O00571 | |
| SSFSSSRASSSRSGG | 611 | O00571 | |
| RATSSTSVTNSTGSA | 921 | Q8WXI7 | |
| TGIASDSSSDSSSSS | 336 | Q6NYC1 | |
| FSSASSLSSSSTSAG | 436 | Q14774 | |
| TSSCSQLSSSSGSSS | 1216 | Q4ZG55 | |
| TNSESSTTSSGASTA | 106 | Q5SSG8 | |
| STTSSGASTATNSES | 111 | Q5SSG8 | |
| GASTATNSDSSTTSS | 131 | Q5SSG8 | |
| TNSDSSTTSSGASTA | 136 | Q5SSG8 | |
| STTSSGASTATNSDS | 141 | Q5SSG8 | |
| GASTATNSDSSTTSS | 146 | Q5SSG8 | |
| TNSESSTTSSGASTA | 166 | Q5SSG8 | |
| STTSSGASTATNSES | 171 | Q5SSG8 | |
| GASTATNSESSTVSS | 176 | Q5SSG8 | |
| TNSESSTTSSGASTA | 196 | Q5SSG8 | |
| STTSSGASTATNSES | 201 | Q5SSG8 | |
| TNSESSTTSSGASTA | 226 | Q5SSG8 | |
| STTSSGASTATNSES | 231 | Q5SSG8 | |
| GANTATNSESSTTSS | 296 | Q5SSG8 | |
| TNSESSTTSSGANTA | 301 | Q5SSG8 | |
| STTSSGANTATNSDS | 306 | Q5SSG8 | |
| GANTATNSDSSTTSS | 311 | Q5SSG8 | |
| TNSDSSTTSSGASTA | 316 | Q5SSG8 | |
| STTSSGASTATNSES | 321 | Q5SSG8 | |
| GASTATNSESSTTSS | 326 | Q5SSG8 | |
| TNSESSTTSSGASTA | 331 | Q5SSG8 | |
| STTSSGASTATNSES | 336 | Q5SSG8 | |
| GASTATNSESSTTSS | 341 | Q5SSG8 | |
| TNSESSTTSSGASTA | 346 | Q5SSG8 | |
| TNSESSTVSSGASTA | 376 | Q5SSG8 | |
| STTSSGASTATNSES | 396 | Q5SSG8 | |
| GASTATNSESSTVSS | 401 | Q5SSG8 | |
| TNSESSTVSSGASTA | 406 | Q5SSG8 | |
| STVSSGASTATNSES | 411 | Q5SSG8 | |
| GASTATNSESSTTSS | 416 | Q5SSG8 | |
| TNSESSTTSSGANTA | 421 | Q5SSG8 | |
| NSSVSSSSSSSGCQS | 16 | Q96S65 | |
| FSSGSQSSRDVTSSS | 431 | P02533 | |
| SDLTSSSSSSSGLSF | 4136 | Q2LD37 | |
| NSSSSSTDSRSRSSS | 411 | Q96PV6 | |
| TSSASVTTTSNASGR | 436 | P13646 | |
| SSTSDGDRSVSSQSS | 201 | Q9NXV6 | |
| GDRSVSSQSSSSVSS | 206 | Q9NXV6 | |
| SSGSSSSSGSSSSRS | 591 | Q9H307 | |
| SSSSSSSTSGSSSRD | 606 | Q9H307 | |
| SSTSGSSSRDSSSST | 611 | Q9H307 | |
| PSESSSSTSSSSSRQ | 1866 | Q8IVL0 | |
| RNSGSSLVSSSSASS | 111 | O60447 | |
| AVTRSTSSTSSGSNS | 2326 | O94915 | |
| ERSSSSSSSSSESGS | 31 | O14511 | |
| SSSSSSESGSSSRSS | 36 | O14511 | |
| SESGSSSRSSSNNSS | 41 | O14511 | |
| NRSIQGSSTSSSASS | 176 | Q9P265 | |
| TNSTTSADVTGSSAS | 461 | Q9ULI3 | |
| AQATSSSSSTSAAAA | 51 | Q6VY07 | |
| SSSSSSSNAESGTES | 91 | Q5XG87 | |
| GRSHSSGSSSSSSSE | 671 | Q9H4Z3 | |
| SGRYSSSSSSSSDSS | 101 | Q5BKY9 | |
| SRTSSSSSSDSSTNL | 211 | Q9BQY9 | |
| RSSSSGDQSSDSLNS | 306 | P15408 | |
| NSSTSTSSSGSRRNA | 241 | Q8N6U8 | |
| SQSSLVSNSSSGSSS | 326 | Q7Z589 | |
| AVTRSTSSTSSGSNS | 2361 | Q5TBA9 | |
| IQGSSTSSSASSTSS | 171 | Q14689 | |
| SEGNSVSSSSSSSSS | 906 | Q9UHL9 | |
| SSGSNRTSEASSSSS | 1431 | Q5VV67 | |
| SSFSSSGSSMSSSQN | 1271 | Q15648 | |
| ASSSSSSSSSNNGSA | 121 | Q02446 | |
| LDGSSSSASSTATSN | 531 | O94972 | |
| GSSSTRSRSSSTSSS | 71 | Q15287 | |
| RSRSSSTSSSGSSTS | 76 | Q15287 | |
| TGSSSGSSSSSASSR | 91 | Q15287 | |
| GSSSSSASSRSGSSS | 96 | Q15287 | |
| SASSRSGSSSTSRSS | 101 | Q15287 | |
| RSSSSTSSVSSTAGE | 636 | Q684P5 | |
| SSSSSSGSSSSDSEG | 2551 | Q9UQ35 | |
| SFTESSSATTNSTGN | 201 | Q9P0V3 | |
| LSSSTSNGTDSTQTS | 186 | Q8N3X1 | |
| SSSSSSRASSQSNST | 36 | P0DPB3 | |
| STTSSSGSSCDSRSA | 21 | A1L390 | |
| GSQSSDSSSSLSSHR | 1951 | O75376 | |
| SDFGSSLSSSSNSVS | 396 | Q1XH10 | |
| SSTESDSSSGSSQVS | 446 | Q1XH10 | |
| STSRGSSSRQSSTAA | 171 | Q6UWI4 | |
| SSSRQSSTAASSSSS | 176 | Q6UWI4 | |
| SSTAASSSSSANSGA | 181 | Q6UWI4 | |
| LSASSSSSASSSSGS | 1041 | Q9UPS6 | |
| SEGSRSSSSSSSSNN | 426 | Q01113 | |
| GSSSSSSRASSQSNS | 111 | B3KU38 | |
| DSSSSFSSSSRSGSS | 41 | Q6UX06 | |
| SSSSSSSQFRSSDAN | 351 | O15047 | |
| SSSRSSSRATSAGSS | 16 | Q9BXB5 | |
| SGSRSSTRTSTSSSS | 116 | O43597 | |
| STSGSRDLSSSSSLS | 531 | Q8WZ75 | |
| SVDGSDSSLSSQSSS | 1706 | Q8IY92 | |
| SSRSGSSSTRSTANS | 296 | Q9H6B4 | |
| TSVSSSASSGASLSS | 746 | Q5T6F2 | |
| SSSSSNSTSNEASGT | 626 | O95625 | |
| SSSSSSTGETQTQSS | 381 | Q7Z417 | |
| ERNKSSSSSSSSSSS | 46 | Q8WWA1 | |
| SDAAGASSSSASSSS | 561 | O14492 | |
| AESVSSSGSSSSSNS | 4186 | Q86WI1 | |
| SSGSSSSSNSKASTV | 4191 | Q86WI1 | |
| SAGSRTSSSVSSTSA | 776 | O15195 | |
| SISSSSSDSLGSSSS | 1181 | A7E2V4 | |
| DSSTSSSSSSSGVFS | 1046 | Q9UPU5 | |
| GSSSSGSSSSNSRTS | 511 | Q8TF01 | |
| GSSSSNSRTSSTSST | 516 | Q8TF01 | |
| VSSSSYSSSSGSSRT | 531 | Q8TF01 | |
| SRASTSSSSSSSSNQ | 6 | P51965 | |
| RSSSFGSVSTSSNSS | 26 | P57768 | |
| ASSASASNSSRSSSR | 546 | Q86VM9 |